网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
心力衰竭患儿预后危险因素的多元Cox模型分析
作者:姚玉婷  陈梅 
单位:南京医科大学附属儿童医院 心血管内科, 江苏 南京 210000
关键词:心力衰竭 预后 危险因素 
分类号:R725.4
出版年·卷·期(页码):2024·52·第六期(910-915)
摘要:

目的: 探究心力衰竭(HF)患儿预后危险因素,为预后评定提供依据。方法: 回顾性分析2020年6月至2022年8月南京医科大学附属儿童医院107例HF患儿临床资料,依据患儿6个月预后情况分为预后不良组、预后良好组。采用Cox多因素回归分析确定HF患儿预后的影响因素;绘制受试者操作特征曲线(ROC)确定影响因素对患儿预后的预测价值。结果: 107例HF患儿中出现心血管事件死亡9例,由于HF加重再次住院20例,预后不良共29例(27.10%),归为预后不良组;未出现心血管事件死亡且未出现HF加重再次住院78例(72.90%),归为预后良好组。Cox多因素回归分析显示,改良ROSS评分与B型利钠肽(BNP)、红细胞分布宽度(RDW)、超敏-C反应蛋白(hs-CRP)均为HF患儿预后不良的危险因素,白蛋白(ALB)、血清钠(Na+)为保护因素(P<0.05)。绘制ROC曲线显示,改良ROSS评分与BNP、RDW、hs-CRP、ALB、Na+均对HF患儿预后不良有一定预测效力,AUC分别为0.795、0.848、0.705、0.830、0.729、0.754。结论: HF患儿预后影响因素包括改良ROSS评分、BNP、RDW、hs-CRP、ALB、Na+,对预后预测价值良好。

Objective: To explore the prognostic risk factors of children with heart failure(HF), and to provide a basis for prognosis evaluation. Methods: The clinical data of 107 children with HF admitted to the Nanjing Children's Hospital from June 2020 to August 2022 were retrospectively collected. According to the prognosis of 6 months, the children were divided into poor prognosis group and good prognosis group. Cox multivariate regression analysis was used to determine the influencing factors for the prognosis in children with HF. Receiver operating characteristic curve(ROC) was drawn to determine the predictive value of influencing factors for the prognosis of children. Results: Among 107 children with HF, 9 cases died of cardiovascular events, 20 cases were hospitalized again due to HF aggravation, 29 cases(27.10%) had poor prognosis, who were classified into poor prognosis group; there were 78 cases(72.90%) of rehospitalization without cardiovascular event death and HF aggravation, who were classified into good prognosis group. Cox multivariate regression analysis showed that the modified ROSS score, b-type natriuretic peptide(BNP), red blood cell distribution width(RDW), high-sensitivity C-reactive protein(hs-CRP) were risk factors for poor prognosis in children with HF, and albumin(ALB), serum natrium(Na+) were protective factors(P<0.05). The ROC curve showed that the improved ROSS score and BNP, RDW, hs-CRP, ALB, Na+ had a certain predictive effect on the poor prognosis of children with HF, and the AUC was 0.795, 0.848, 0.705, 0.830, 0.729 and 0.754, respectively. Conclusion: The prognostic factors of children with HF include modified ROSS score, BNP, RDW, hs-CRP, ALB and Na+, which have good predictive value for prognosis.

参考文献:

[1] SANO S,ISHIGAMI S,SANO T.New era of heart failure therapy in pediatrics:cardiac stem cell therapy on the start line[J].J Thorac Cardiovasc Surg,2019,158(3):845-849.
[2] JEAN-ST-MICHEL E,MARELLI A.Advancing knowledge in pediatric heart failure-the growing pains[J].J Card Fail,2019,25(12):959-960.
[3] NAKANO S J,MIYAMOTO S D,PRICE J F,et al.Pediatric heart failure:an evolving public health concern[J].J Pediatr,2020,218:217-221.
[4] SHADDY R E,GEORGE A T,JAECKLIN T,et al.Systematic literature review on the incidence and prevalence of heart failure in children and adolescents[J].Pediatr Cardiol,2018,39(3):415-436.
[5] PRICE J F,YOUNAN S,CABRERA A G,et al.Diuretic responsiveness and its prognostic significance in children with heart failure[J].J Card Fail,2019,25(12):941-947.
[6] LASA J J,GAIES M,BUSH L,et al.Epidemiology and outcomes of acute decompensated heart failure in children[J].Circ Heart Fail,2020,13(4):e006101.
[7] BICHALI S,MALOREY D,BENBRIK N,et al.Measurement,consequences and determinants of time to diagnosis in children with new-onset heart failure:a population-based retrospective study(DIACARD study)[J].Int J Cardiol,2020,318:87-93.
[8] 中华医学会儿科学分会心血管学组,中国医师协会心血管内科医师分会儿童心血管专业委员会,中华儿科杂志编辑委员会.儿童心力衰竭诊断和治疗建议(2020年修订版)[J].中华儿科杂志,2021,59(2):84-94.
[9] ELZAYAT R S,BAHBAH W A,ELZAIAT R S,et al.Fibroblast growth factor 23 in children with or without heart failure:a prospective study[J].BMJ Paediatr Open,2023,7(1):e001753.
[10] 金伶,杨彤,龙兴江.低钠血症对心力衰竭患儿预后的影响[J].临床儿科杂志,2019,37(10):752-755.
[11] 李舒承,王虹,黄贤胜,等.三七总皂苷对慢性心力衰竭大鼠心脏功能、血浆利钠肽及血管紧张素Ⅱ的影响[J].东南大学学报(医学版),2019,38(4):638-642.
[12] SALEM S S,SALEH N Y,SOLIMAN S E,et al.On-admission plasma levels of BNP,MR-proADM,and cTnI in pediatric heart failure:contributions to diagnosis,prognosis,and outcome[J].Ir J Med Sci,2022,191(1):263-270.
[13] BAI J,HAN L,LIU H.Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure[J].Ann Palliat Med,2020,9(4):1976-1989.
[14] GUO M,LUO J,ZHAO J,et al.Combined use of circulating miR-133a and NT-proBNP improves heart failure diagnostic accuracy in elderly patients[J].Med Sci Monit,2018,24:8840-8848.
[15] BLANCO R,AMBROSIO G,BELZITI C,et al.Prognostic value of NT-proBNP,and echocardiographic indices of diastolic function,in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction[J].Int J Cardiol,2020,317:111-120.
[16] 沈英豪,张俊峰,张欣,等.红细胞体积分布宽度对心力衰竭患者病情及预后转归的评估价值[J].现代生物医学进展,2019,19(6):1060-1063.
[17] 王媛媛,梁静,李东升.红细胞分布宽度与急性心力衰竭患者1年死亡率的相关性分析研究[J].中国循证心血管医学杂志,2021,13(5):630-633.
[18] 金伶,龙兴江,杨彤,等.血清白蛋白联合红细胞体积分布宽度对心力衰竭严重程度的评估价值[J].临床儿科杂志,2018,36(5):360-363.
[19] 吴立华,刘倩,高丽娜,等.N末端B型利钠肽原联合超敏C反应蛋白评价射血分数降低心力衰竭病人病情及预后的临床价值[J].中西医结合心脑血管病杂志,2020,18(16):2677-2679.
[20] 李琼,王磊,高波.高敏C反应蛋白、B型钠尿肽联合检测对慢性心力衰竭诊治及预后的评估价值[J].国际老年医学杂志,2020,41(2):90-91,99.
[21] NI Q,WANG X,WANG J,et al.The red blood cell distribution width-albumin ratio:a promising predictor of mortality in heart failure patients—a cohort study[J].Clin Chim Acta,2022,527:38-46.
[22] LI K,FU W,BO Y,et al.Effect of albumin-globulin score and albumin to globulin ratio on survival in patients with heart failure:a retrospective cohort study in China[J].BMJ Open,2018,8(7):e022960.
[23] 巫雪飞,宋静,赵亚男,等.持续性低钠血症对射血分数降低的心力衰竭患者全因死亡的预测价值[J].中国循环杂志,2022,37(1):52-56.
[24] 何微,王传合,谢嘉怡,等.低钠血症对心力衰竭患者院内死亡的影响[J].中国医科大学学报,2022,51(8):712-715.
[25] MILANI G P,BIANCHETTI M G,LAVA S A.Measurement of sodium in heart failure[J].Heart,2018,104(20):1724.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 820757 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541